IGF-II mRNA and protein are expressed in the stroma of invasive breast cancers: Anin situ hybridization and immunohistochemistry study
- 42 Downloads
Insulin-like growth factor-II (IGF-II) is a potent mitogen for a variety of cell types and is considered an important regulator of breast cancer growth. In this study, we analyzed IGF-II mRNA and protein expression in a series of 80 cases of invasive breast cancer. Seventy-five cases produced informative results for IGF-II mRNA expression, and were scored on an arbitrary scale. Two cases (2.6%) had no significant IGF-II mRNA expression. 35 cases (46.7%) expressed low levels of IGF-II mRNA, 20 cases (26.7%) moderate IGF-II mRNA, while 18 (24%) expressed high levels of IGF-II message. Generally, IGF-II mRNA was expressed in the smooth muscle walls of blood vessels and ducts, as well as in the stroma tightly adjacent to and surrounding tumor epithelium. IGF-II mRNA content was also directly related to the amount of the stroma within the tumor (p<0.05). In 10 cases (13.3%) IGF-II mRNA was detected in the stroma of normal lobules. Fifty-six out of 75 were positive for IGF-II immunostaining. Again, protein staining was generally observed in the smooth muscle of both blood vessels and ducts, as well as in the stroma surrounding tumor epithelium. In normal lobules and ducts the IGF-II protein was detected in the myoepithelium. Unequivocal IGF-II protein staining was seen in tumor epithelium in only three cases. The results of our study demonstrate that, in breast cancer, IGF-II mRNA is expressed in the smooth muscle and stromal components in the majority of invasive breast cancers. IGF-II expression correlates positively with the amount of stromal tissue present within a tumor. This suggests that IGF-II may have an important growth regulatory effect on breast tumor epithelium through paracrine pathways.
Key wordsIGF-II breast cancer immunohistochemistry in situ hybridization
Unable to display preview. Download preview PDF.
- 6.Furlanetto RW, Dicarlo JN: Somatomedin-C receptors and growth effects in human breast cells maintained in longterm tissue culture. Cancer Res 48: 2122–2128, 1984Google Scholar
- 13.Bondy C: Mapping of brain insulin-like growth factor receptor gene expression byin situ hybridization. Neuroprotocols 1: 240–249, 1992Google Scholar
- 15.Giani C, Campani D, De Negri F, Capotorti E, Savarese M, Benigni G, Incensati R, Breccia M, Miccoli P, Evangelista G, Squartini F, Pinchera A: Relationship between progesterone receptor, axillary node status and productive fibrosis in ductal infiltrating carcinoma of the breast. Appl Pathol 7: 225–232, 1989PubMedGoogle Scholar
- 16.Adams EF, Newton CJ, Braunsberg H, Shaikh N, Ghilchic M, James VH: Effects of human breast fibroblasts on growth and 17beta estradiol dehydrogenase activity of MCF-7 in culture. Breast Cancer Res Treat 11: 162–172, 1988Google Scholar
- 17.Camps JL, Chang SM, Hsu TC, Freeman MR, Hong SJ, Zhau HE, Von Eschenbach AC, Chung LWK: Proc Natl Acad Sci USA 87: 75–79, 1990Google Scholar
- 18.Bronzert DA, Pantazis P, Antoniades HN, Kasid A, Davidson N, Dickson RB, Lippman ME: Synthesis and secretion of platelet derived growth factor by human breast cancer cell lines. Proc Natl Acad Sci (USA) 84: 5763–5767, 1987Google Scholar
- 20.Nelson CF: The molecular and cellular biology of insulinlike growth factor II. Prog in Growth Factor Res 4: 257–290, 1992Google Scholar
- 25.Azzarone B, Maciera-Coelho A: Further characterization of the defects of skin fibroblasts from cancer patients. J Cell Sci 87: 155–162Google Scholar